MedTrace Logo

Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy

NCT03106389 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2017-05-09

No results posted yet for this study

Summary

This randomized controlled study will be performed to compare the benefits and risks associated with the administration of misoprostol with or without the use of a transcervical balloon catheter to terminate pregnancy in the second trimester (defined as gestational age between 14 and 28 weeks of gestation).

Conditions

  • Pregnancy Trimester, Second
  • Misoprostol
  • Catheters
  • Abortion, Second Trimester

Interventions

DRUG

Misoprostol

400 micro grams misoprostol administered vaginally followed every 6 hours by 400 micro grams orally until complete expulsion

DEVICE

Misoprostol/Transcervical catheter

Foleys' catheter introduced into the cervix and inflated with 30 ml. of fluid; weighted traction applied by using a 1000 ml fluid-filled bag

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Principal Investigators

  • Alaa Elfeky, Professor · AinShams University Maternity Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2017-06-30
Completion
2017-07-31

Countries

  • Egypt

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03106389 on ClinicalTrials.gov